Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 15 04:00PM ET
265.51
Dollar change
-1.77
Percentage change
-0.66
%
IndexDJIA, NDX, S&P 500 P/E21.27 EPS (ttm)12.48 Insider Own0.25% Shs Outstand535.40M Perf Week-1.37%
Market Cap142.29B Forward P/E12.64 EPS next Y21.01 Insider Trans-0.89% Shs Float534.60M Perf Month-2.22%
Income6.72B PEG4.05 EPS next Q3.89 Inst Own78.00% Short Float1.96% Perf Quarter-13.38%
Sales28.01B P/S5.08 EPS this Y4.75% Inst Trans-1.47% Short Ratio3.56 Perf Half Y-6.85%
Book/sh11.64 P/B22.81 EPS next Y7.55% ROA8.28% Short Interest10.47M Perf Year5.60%
Cash/sh20.42 P/C13.00 EPS next 5Y5.25% ROE135.79% 52W Range211.71 - 329.72 Perf YTD-7.82%
Dividend Est.9.29 (3.50%) P/FCF19.34 EPS past 5Y-0.22% ROI9.58% 52W High-19.47% Beta0.61
Dividend TTM8.64 (3.25%) Quick Ratio1.13 Sales past 5Y3.42% Gross Margin69.83% 52W Low25.41% ATR (14)5.36
Dividend Ex-DateMay 16, 2024 Current Ratio1.65 EPS Y/Y TTM3.15% Oper. Margin29.34% RSI (14)36.87 Volatility1.56% 1.75%
Employees26700 Debt/Eq10.50 Sales Y/Y TTM7.35% Profit Margin23.98% Recom2.29 Target Price306.11
Option/ShortYes / Yes LT Debt/Eq10.25 EPS Q/Q-52.62% Payout68.24% Rel Volume0.59 Prev Close267.28
Sales Surprise0.15% EPS Surprise2.58% Sales Q/Q20.42% EarningsMay 02 AMC Avg Volume2.94M Price265.51
SMA20-3.20% SMA50-5.97% SMA200-1.87% Trades Volume1,732,777 Change-0.66%
Date Action Analyst Rating Change Price Target Change
Mar-28-24Resumed Raymond James Mkt Perform
Feb-07-24Downgrade Leerink Partners Outperform → Market Perform $324 → $318
Dec-21-23Upgrade Daiwa Securities Neutral → Buy $264 → $320
Dec-19-23Upgrade BMO Capital Markets Market Perform → Outperform $286 → $326
Dec-12-23Upgrade RBC Capital Mkts Sector Perform → Outperform $256 → $300
Nov-09-23Initiated Deutsche Bank Hold $240
Nov-02-23Upgrade Truist Hold → Buy $260 → $320
Oct-20-23Resumed JP Morgan Neutral $265 → $270
Oct-17-23Resumed Morgan Stanley Equal-Weight $300
Oct-11-23Resumed BofA Securities Neutral $290
Apr-15-24 03:07PM
09:07AM
Apr-13-24 12:18PM
Apr-12-24 02:48PM
Apr-11-24 06:00PM
08:00AM Loading…
08:00AM
Apr-10-24 03:30PM
09:27AM
Apr-09-24 07:37AM
07:00AM
Apr-07-24 02:00PM
07:07AM
07:07AM
Apr-06-24 08:47PM
07:01PM
08:45AM Loading…
08:45AM
Apr-05-24 05:50PM
04:05AM
Apr-04-24 07:38AM
Apr-03-24 11:14AM
Apr-01-24 06:00PM
12:10PM
Mar-30-24 03:52PM
Mar-29-24 09:00AM
08:05AM
Mar-27-24 01:07PM
06:00AM
Mar-25-24 05:50PM
01:05PM
Mar-24-24 10:58AM
10:42AM Loading…
10:42AM
Mar-21-24 05:29PM
07:00AM
Mar-20-24 03:46PM
12:39AM
Mar-19-24 05:50PM
08:32AM
Mar-18-24 06:00PM
09:00AM
Mar-14-24 09:37AM
09:26AM
Mar-12-24 08:30AM
06:46AM
Mar-11-24 05:50PM
12:44PM
08:02AM
Mar-10-24 03:05PM
Mar-09-24 12:20PM
Mar-07-24 12:02PM
11:56AM
11:31AM
Mar-06-24 04:00PM
09:00AM
07:45AM
Mar-04-24 05:50PM
10:06AM
Feb-29-24 04:00PM
01:55PM
09:45AM
04:47AM
Feb-26-24 09:00AM
08:50AM
Feb-23-24 09:00AM
05:43AM
Feb-22-24 10:09AM
Feb-19-24 04:00PM
Feb-18-24 05:07AM
Feb-17-24 08:13AM
Feb-14-24 05:13AM
02:59AM
01:18AM
Feb-13-24 02:16PM
Feb-12-24 09:00AM
Feb-10-24 08:30AM
Feb-09-24 04:00PM
06:01AM
Feb-08-24 06:58PM
Feb-07-24 07:37PM
04:12PM
03:22PM
11:16AM
10:52AM
10:45AM
10:37AM
10:32AM
09:55AM
07:21AM
05:06AM
Feb-06-24 08:00PM
05:10PM
04:52PM
04:40PM
04:37PM
04:16PM
04:08PM
04:04PM
04:02PM
04:01PM
06:00AM
Feb-05-24 04:35PM
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Grygiel Nancy A.SVP & CCODec 04 '23Sale273.032,096572,27610,874Dec 04 07:41 PM
Graham Jonathan PEVP, Gen. Counsel & Secy.Nov 08 '23Sale272.8110,0002,728,13628,078Nov 13 08:30 PM
AMGEN INC10% OwnerSep 19 '23Buy17.001,764,70529,999,98535,368,653Sep 19 07:52 PM
Gordon MurdoEVP, Global Commercial OpsAug 10 '23Sale262.439,5582,508,30644,308Aug 11 06:13 PM